Fundamental principles of an effective diabetic retinopathy screening program

Background Diabetic retinopathy (DR) is the leading cause of blindness among working-age adults worldwide. Early detection and treatment are necessary to forestall vision loss from DR. Methods A working group of ophthalmic and diabetes experts was established to develop a consensus on the key princi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta diabetologica 2020-07, Vol.57 (7), p.785-798
Hauptverfasser: Lanzetta, Paolo, Sarao, Valentina, Scanlon, Peter H., Barratt, Jane, Porta, Massimo, Bandello, Francesco, Loewenstein, Anat
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 798
container_issue 7
container_start_page 785
container_title Acta diabetologica
container_volume 57
creator Lanzetta, Paolo
Sarao, Valentina
Scanlon, Peter H.
Barratt, Jane
Porta, Massimo
Bandello, Francesco
Loewenstein, Anat
description Background Diabetic retinopathy (DR) is the leading cause of blindness among working-age adults worldwide. Early detection and treatment are necessary to forestall vision loss from DR. Methods A working group of ophthalmic and diabetes experts was established to develop a consensus on the key principles of an effective DR screening program. Recommendations are based on analysis of a structured literature review. Results The recommendations for implementing an effective DR screening program are: (1) Examination methods must be suitable for the screening region, and DR classification/grading systems must be systematic and uniformly applied. Two-field retinal imaging is sufficient for DR screening and is preferable to seven-field imaging, and referable DR should be well defined and reliably identifiable by qualified screening staff; (2) in many countries/regions, screening can and should take place outside the ophthalmology clinic; (3) screening staff should be accredited and show evidence of ongoing training; (4) screening programs should adhere to relevant national quality assurance standards; (5) studies that use uniform definitions of risk to determine optimum risk-based screening intervals are required; (6) technology infrastructure should be in place to ensure that high-quality images can be stored securely to protect patient information; (7) although screening for diabetic macular edema (DME) in conjunction with DR evaluations may have merit, there is currently insufficient evidence to support implementation of programs solely for DME screening. Conclusion Use of these recommendations may yield more effective DR screening programs that reduce the risk of vision loss worldwide.
doi_str_mv 10.1007/s00592-020-01506-8
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7311555</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2384493820</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-6e1ce0b995ece743f47d3232986ffea1f6714eeb5588ac063eb36d625dcbde993</originalsourceid><addsrcrecordid>eNp9kc1u1TAQhS0EopfCC7BAkdiwCYw9dmJvkFBFAamIDawtx5ncukrsi51U6tvjckv5WeCFvfB3zpzRYew5h9ccoH9TAJQRLQhogSvoWv2A7bhE0SqB-JDtwEholRTmhD0p5QqAix71Y3aCoh7N9Y59Pt_i6BaKq5ubQw7Rh8NMpUlT42JD00R-DdfUjMENtAbf5HrHdHDr5U1TfCaKIe6rMu2zW56yR5ObCz27e0_Zt_P3X88-thdfPnw6e3fRetnLte2Ie4LBGEWeeomT7EcUKIzu6kDHp67nkmhQSmvnoUMasBs7oUY_jGQMnrK3R9_DNiw0-ho_u9nW_IvLNza5YP_-ieHS7tO17ZFzpVQ1eHVnkNP3jcpql1A8zbOLlLZiBWopDWoBFX35D3qVthzrelZI3iHXBnmlxJHyOZWSaboPw8HetmWPbdnalv3ZltVV9OLPNe4lv-qpAB6BclvNnvLv2f-x_QH2-KGd</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2416318931</pqid></control><display><type>article</type><title>Fundamental principles of an effective diabetic retinopathy screening program</title><source>MEDLINE</source><source>SpringerLink (Online service)</source><creator>Lanzetta, Paolo ; Sarao, Valentina ; Scanlon, Peter H. ; Barratt, Jane ; Porta, Massimo ; Bandello, Francesco ; Loewenstein, Anat</creator><creatorcontrib>Lanzetta, Paolo ; Sarao, Valentina ; Scanlon, Peter H. ; Barratt, Jane ; Porta, Massimo ; Bandello, Francesco ; Loewenstein, Anat ; Vision Academy ; the Vision Academy</creatorcontrib><description>Background Diabetic retinopathy (DR) is the leading cause of blindness among working-age adults worldwide. Early detection and treatment are necessary to forestall vision loss from DR. Methods A working group of ophthalmic and diabetes experts was established to develop a consensus on the key principles of an effective DR screening program. Recommendations are based on analysis of a structured literature review. Results The recommendations for implementing an effective DR screening program are: (1) Examination methods must be suitable for the screening region, and DR classification/grading systems must be systematic and uniformly applied. Two-field retinal imaging is sufficient for DR screening and is preferable to seven-field imaging, and referable DR should be well defined and reliably identifiable by qualified screening staff; (2) in many countries/regions, screening can and should take place outside the ophthalmology clinic; (3) screening staff should be accredited and show evidence of ongoing training; (4) screening programs should adhere to relevant national quality assurance standards; (5) studies that use uniform definitions of risk to determine optimum risk-based screening intervals are required; (6) technology infrastructure should be in place to ensure that high-quality images can be stored securely to protect patient information; (7) although screening for diabetic macular edema (DME) in conjunction with DR evaluations may have merit, there is currently insufficient evidence to support implementation of programs solely for DME screening. Conclusion Use of these recommendations may yield more effective DR screening programs that reduce the risk of vision loss worldwide.</description><identifier>ISSN: 0940-5429</identifier><identifier>ISSN: 1432-5233</identifier><identifier>EISSN: 1432-5233</identifier><identifier>DOI: 10.1007/s00592-020-01506-8</identifier><identifier>PMID: 32222818</identifier><language>eng</language><publisher>Milan: Springer Milan</publisher><subject>Adult ; Blindness ; Consensus ; Diabetes ; Diabetes mellitus ; Diabetes Mellitus - diagnosis ; Diabetes Mellitus - pathology ; Diabetic retinopathy ; Diabetic Retinopathy - diagnosis ; Edema ; Eye Complications of Diabetes ; Female ; Humans ; Internal Medicine ; Literature reviews ; Macular Edema - diagnosis ; Male ; Mass Screening - methods ; Mass Screening - organization &amp; administration ; Mass Screening - standards ; Medicine ; Medicine &amp; Public Health ; Metabolic Diseases ; Middle Aged ; Position Statement ; Practice Guidelines as Topic ; Program Evaluation - methods ; Program Evaluation - standards ; Quality assurance ; Referral and Consultation - organization &amp; administration ; Referral and Consultation - standards ; Retinopathy ; Telemedicine ; Vision</subject><ispartof>Acta diabetologica, 2020-07, Vol.57 (7), p.785-798</ispartof><rights>The Author(s) 2020. corrected publication 2020</rights><rights>The Author(s) 2020. corrected publication 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2020, corrected publication 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-6e1ce0b995ece743f47d3232986ffea1f6714eeb5588ac063eb36d625dcbde993</citedby><cites>FETCH-LOGICAL-c474t-6e1ce0b995ece743f47d3232986ffea1f6714eeb5588ac063eb36d625dcbde993</cites><orcidid>0000-0003-3746-141X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00592-020-01506-8$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00592-020-01506-8$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,27903,27904,41467,42536,51298</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32222818$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lanzetta, Paolo</creatorcontrib><creatorcontrib>Sarao, Valentina</creatorcontrib><creatorcontrib>Scanlon, Peter H.</creatorcontrib><creatorcontrib>Barratt, Jane</creatorcontrib><creatorcontrib>Porta, Massimo</creatorcontrib><creatorcontrib>Bandello, Francesco</creatorcontrib><creatorcontrib>Loewenstein, Anat</creatorcontrib><creatorcontrib>Vision Academy</creatorcontrib><creatorcontrib>the Vision Academy</creatorcontrib><title>Fundamental principles of an effective diabetic retinopathy screening program</title><title>Acta diabetologica</title><addtitle>Acta Diabetol</addtitle><addtitle>Acta Diabetol</addtitle><description>Background Diabetic retinopathy (DR) is the leading cause of blindness among working-age adults worldwide. Early detection and treatment are necessary to forestall vision loss from DR. Methods A working group of ophthalmic and diabetes experts was established to develop a consensus on the key principles of an effective DR screening program. Recommendations are based on analysis of a structured literature review. Results The recommendations for implementing an effective DR screening program are: (1) Examination methods must be suitable for the screening region, and DR classification/grading systems must be systematic and uniformly applied. Two-field retinal imaging is sufficient for DR screening and is preferable to seven-field imaging, and referable DR should be well defined and reliably identifiable by qualified screening staff; (2) in many countries/regions, screening can and should take place outside the ophthalmology clinic; (3) screening staff should be accredited and show evidence of ongoing training; (4) screening programs should adhere to relevant national quality assurance standards; (5) studies that use uniform definitions of risk to determine optimum risk-based screening intervals are required; (6) technology infrastructure should be in place to ensure that high-quality images can be stored securely to protect patient information; (7) although screening for diabetic macular edema (DME) in conjunction with DR evaluations may have merit, there is currently insufficient evidence to support implementation of programs solely for DME screening. Conclusion Use of these recommendations may yield more effective DR screening programs that reduce the risk of vision loss worldwide.</description><subject>Adult</subject><subject>Blindness</subject><subject>Consensus</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diabetes Mellitus - diagnosis</subject><subject>Diabetes Mellitus - pathology</subject><subject>Diabetic retinopathy</subject><subject>Diabetic Retinopathy - diagnosis</subject><subject>Edema</subject><subject>Eye Complications of Diabetes</subject><subject>Female</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Literature reviews</subject><subject>Macular Edema - diagnosis</subject><subject>Male</subject><subject>Mass Screening - methods</subject><subject>Mass Screening - organization &amp; administration</subject><subject>Mass Screening - standards</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Metabolic Diseases</subject><subject>Middle Aged</subject><subject>Position Statement</subject><subject>Practice Guidelines as Topic</subject><subject>Program Evaluation - methods</subject><subject>Program Evaluation - standards</subject><subject>Quality assurance</subject><subject>Referral and Consultation - organization &amp; administration</subject><subject>Referral and Consultation - standards</subject><subject>Retinopathy</subject><subject>Telemedicine</subject><subject>Vision</subject><issn>0940-5429</issn><issn>1432-5233</issn><issn>1432-5233</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><recordid>eNp9kc1u1TAQhS0EopfCC7BAkdiwCYw9dmJvkFBFAamIDawtx5ncukrsi51U6tvjckv5WeCFvfB3zpzRYew5h9ccoH9TAJQRLQhogSvoWv2A7bhE0SqB-JDtwEholRTmhD0p5QqAix71Y3aCoh7N9Y59Pt_i6BaKq5ubQw7Rh8NMpUlT42JD00R-DdfUjMENtAbf5HrHdHDr5U1TfCaKIe6rMu2zW56yR5ObCz27e0_Zt_P3X88-thdfPnw6e3fRetnLte2Ie4LBGEWeeomT7EcUKIzu6kDHp67nkmhQSmvnoUMasBs7oUY_jGQMnrK3R9_DNiw0-ho_u9nW_IvLNza5YP_-ieHS7tO17ZFzpVQ1eHVnkNP3jcpql1A8zbOLlLZiBWopDWoBFX35D3qVthzrelZI3iHXBnmlxJHyOZWSaboPw8HetmWPbdnalv3ZltVV9OLPNe4lv-qpAB6BclvNnvLv2f-x_QH2-KGd</recordid><startdate>20200701</startdate><enddate>20200701</enddate><creator>Lanzetta, Paolo</creator><creator>Sarao, Valentina</creator><creator>Scanlon, Peter H.</creator><creator>Barratt, Jane</creator><creator>Porta, Massimo</creator><creator>Bandello, Francesco</creator><creator>Loewenstein, Anat</creator><general>Springer Milan</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3746-141X</orcidid></search><sort><creationdate>20200701</creationdate><title>Fundamental principles of an effective diabetic retinopathy screening program</title><author>Lanzetta, Paolo ; Sarao, Valentina ; Scanlon, Peter H. ; Barratt, Jane ; Porta, Massimo ; Bandello, Francesco ; Loewenstein, Anat</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-6e1ce0b995ece743f47d3232986ffea1f6714eeb5588ac063eb36d625dcbde993</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Blindness</topic><topic>Consensus</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diabetes Mellitus - diagnosis</topic><topic>Diabetes Mellitus - pathology</topic><topic>Diabetic retinopathy</topic><topic>Diabetic Retinopathy - diagnosis</topic><topic>Edema</topic><topic>Eye Complications of Diabetes</topic><topic>Female</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Literature reviews</topic><topic>Macular Edema - diagnosis</topic><topic>Male</topic><topic>Mass Screening - methods</topic><topic>Mass Screening - organization &amp; administration</topic><topic>Mass Screening - standards</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Metabolic Diseases</topic><topic>Middle Aged</topic><topic>Position Statement</topic><topic>Practice Guidelines as Topic</topic><topic>Program Evaluation - methods</topic><topic>Program Evaluation - standards</topic><topic>Quality assurance</topic><topic>Referral and Consultation - organization &amp; administration</topic><topic>Referral and Consultation - standards</topic><topic>Retinopathy</topic><topic>Telemedicine</topic><topic>Vision</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lanzetta, Paolo</creatorcontrib><creatorcontrib>Sarao, Valentina</creatorcontrib><creatorcontrib>Scanlon, Peter H.</creatorcontrib><creatorcontrib>Barratt, Jane</creatorcontrib><creatorcontrib>Porta, Massimo</creatorcontrib><creatorcontrib>Bandello, Francesco</creatorcontrib><creatorcontrib>Loewenstein, Anat</creatorcontrib><creatorcontrib>Vision Academy</creatorcontrib><creatorcontrib>the Vision Academy</creatorcontrib><collection>SpringerOpen</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Acta diabetologica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lanzetta, Paolo</au><au>Sarao, Valentina</au><au>Scanlon, Peter H.</au><au>Barratt, Jane</au><au>Porta, Massimo</au><au>Bandello, Francesco</au><au>Loewenstein, Anat</au><aucorp>Vision Academy</aucorp><aucorp>the Vision Academy</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fundamental principles of an effective diabetic retinopathy screening program</atitle><jtitle>Acta diabetologica</jtitle><stitle>Acta Diabetol</stitle><addtitle>Acta Diabetol</addtitle><date>2020-07-01</date><risdate>2020</risdate><volume>57</volume><issue>7</issue><spage>785</spage><epage>798</epage><pages>785-798</pages><issn>0940-5429</issn><issn>1432-5233</issn><eissn>1432-5233</eissn><abstract>Background Diabetic retinopathy (DR) is the leading cause of blindness among working-age adults worldwide. Early detection and treatment are necessary to forestall vision loss from DR. Methods A working group of ophthalmic and diabetes experts was established to develop a consensus on the key principles of an effective DR screening program. Recommendations are based on analysis of a structured literature review. Results The recommendations for implementing an effective DR screening program are: (1) Examination methods must be suitable for the screening region, and DR classification/grading systems must be systematic and uniformly applied. Two-field retinal imaging is sufficient for DR screening and is preferable to seven-field imaging, and referable DR should be well defined and reliably identifiable by qualified screening staff; (2) in many countries/regions, screening can and should take place outside the ophthalmology clinic; (3) screening staff should be accredited and show evidence of ongoing training; (4) screening programs should adhere to relevant national quality assurance standards; (5) studies that use uniform definitions of risk to determine optimum risk-based screening intervals are required; (6) technology infrastructure should be in place to ensure that high-quality images can be stored securely to protect patient information; (7) although screening for diabetic macular edema (DME) in conjunction with DR evaluations may have merit, there is currently insufficient evidence to support implementation of programs solely for DME screening. Conclusion Use of these recommendations may yield more effective DR screening programs that reduce the risk of vision loss worldwide.</abstract><cop>Milan</cop><pub>Springer Milan</pub><pmid>32222818</pmid><doi>10.1007/s00592-020-01506-8</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0003-3746-141X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0940-5429
ispartof Acta diabetologica, 2020-07, Vol.57 (7), p.785-798
issn 0940-5429
1432-5233
1432-5233
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7311555
source MEDLINE; SpringerLink (Online service)
subjects Adult
Blindness
Consensus
Diabetes
Diabetes mellitus
Diabetes Mellitus - diagnosis
Diabetes Mellitus - pathology
Diabetic retinopathy
Diabetic Retinopathy - diagnosis
Edema
Eye Complications of Diabetes
Female
Humans
Internal Medicine
Literature reviews
Macular Edema - diagnosis
Male
Mass Screening - methods
Mass Screening - organization & administration
Mass Screening - standards
Medicine
Medicine & Public Health
Metabolic Diseases
Middle Aged
Position Statement
Practice Guidelines as Topic
Program Evaluation - methods
Program Evaluation - standards
Quality assurance
Referral and Consultation - organization & administration
Referral and Consultation - standards
Retinopathy
Telemedicine
Vision
title Fundamental principles of an effective diabetic retinopathy screening program
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T17%3A38%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fundamental%20principles%20of%20an%20effective%20diabetic%20retinopathy%20screening%20program&rft.jtitle=Acta%20diabetologica&rft.au=Lanzetta,%20Paolo&rft.aucorp=Vision%20Academy&rft.date=2020-07-01&rft.volume=57&rft.issue=7&rft.spage=785&rft.epage=798&rft.pages=785-798&rft.issn=0940-5429&rft.eissn=1432-5233&rft_id=info:doi/10.1007/s00592-020-01506-8&rft_dat=%3Cproquest_pubme%3E2384493820%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2416318931&rft_id=info:pmid/32222818&rfr_iscdi=true